Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina Kinge

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Laeknabladid|September 13, 2005
[Age Related Macular Degeneration--a review]Olafur Már Björnsson, Bettina Kinge
Acta Ophthalmologica|May 7, 2009
Retinal artery occlusion following intravitreal anti-VEGF therapyTherese von Hanno, Bettina Kinge, Kristian Fossen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 27, 2004
[Retinoblastoma--hereditary eye cancer in children]Bettina Kinge, Randi Skarpaas Tranheim, Nils A Eide
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 13, 2004
[Prevalence of refractive errors in Norway]Anna Midelfart, Bettina Kinge, Sven Midelfart, et al.
Acta Ophthalmologica Scandinavica|October 23, 2002
Prevalence of refractive errors in young and middle-aged adults in NorwayAnna Midelfart, Bettina Kinge, Sven Midelfart, et al.
Acta Ophthalmologica Scandinavica|September 13, 2006
The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular studyOlafur M Björnsson, Per Syrdalen, Alan C Bird, et al.
American Journal of Ophthalmology|July 2, 2010
Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC studyBettina Kinge, Per Bjørn Stordahl, Vegard Forsaa, et al.
Ophthalmology|October 20, 2015
Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol: Two-Year ResultsKarina Berg, Emina Hadzalic, Inger Gjertsen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Laeknabladid|September 13, 2005
[Age Related Macular Degeneration--a review]Olafur Már Björnsson, Bettina Kinge
Acta Ophthalmologica|May 7, 2009
Retinal artery occlusion following intravitreal anti-VEGF therapyTherese von Hanno, Bettina Kinge, Kristian Fossen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 27, 2004
[Retinoblastoma--hereditary eye cancer in children]Bettina Kinge, Randi Skarpaas Tranheim, Nils A Eide
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 13, 2004
[Prevalence of refractive errors in Norway]Anna Midelfart, Bettina Kinge, Sven Midelfart, et al.
Acta Ophthalmologica Scandinavica|October 23, 2002
Prevalence of refractive errors in young and middle-aged adults in NorwayAnna Midelfart, Bettina Kinge, Sven Midelfart, et al.
Acta Ophthalmologica Scandinavica|September 13, 2006
The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular studyOlafur M Björnsson, Per Syrdalen, Alan C Bird, et al.
American Journal of Ophthalmology|July 2, 2010
Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC studyBettina Kinge, Per Bjørn Stordahl, Vegard Forsaa, et al.
Ophthalmology|October 20, 2015
Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol: Two-Year ResultsKarina Berg, Emina Hadzalic, Inger Gjertsen, et al.
Pageof 1